MedTrace Logo

Observational Study of Delayed Nausea and Vomiting

NCT00696280 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2013-06-12

No results posted yet for this study

Summary

Delayed emesis following administration of carboplatin-based chemotherapy despite prophylaxis with standard antiemetic prophylaxis (5-HT3 and corticosteroid) remains a clinically significant and distressing problem for patients with cancer. The incidence of delayed emesis appears to be higher in women compared to men.

Conditions

Interventions

BEHAVIORAL

Functional Living Index - Emesis

Sponsors & Collaborators

Principal Investigators

  • Maria Q Baggstrom, M.D. · Washington University School of Mecicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00696280 on ClinicalTrials.gov